1. Home
  2. MDV vs IPSC Comparison

MDV vs IPSC Comparison

Compare MDV & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDV
  • IPSC
  • Stock Information
  • Founded
  • MDV 2015
  • IPSC 2019
  • Country
  • MDV United States
  • IPSC United States
  • Employees
  • MDV N/A
  • IPSC N/A
  • Industry
  • MDV Transportation Services
  • IPSC Medicinal Chemicals and Botanical Products
  • Sector
  • MDV Consumer Discretionary
  • IPSC Health Care
  • Exchange
  • MDV Nasdaq
  • IPSC Nasdaq
  • Market Cap
  • MDV 156.7M
  • IPSC 149.1M
  • IPO Year
  • MDV 2022
  • IPSC 2021
  • Fundamental
  • Price
  • MDV $16.13
  • IPSC $1.24
  • Analyst Decision
  • MDV Strong Buy
  • IPSC Strong Buy
  • Analyst Count
  • MDV 1
  • IPSC 4
  • Target Price
  • MDV $18.00
  • IPSC $13.00
  • AVG Volume (30 Days)
  • MDV 39.7K
  • IPSC 485.8K
  • Earning Date
  • MDV 11-06-2024
  • IPSC 11-05-2024
  • Dividend Yield
  • MDV 7.14%
  • IPSC N/A
  • EPS Growth
  • MDV N/A
  • IPSC N/A
  • EPS
  • MDV N/A
  • IPSC N/A
  • Revenue
  • MDV $47,416,592.00
  • IPSC $2,684,000.00
  • Revenue This Year
  • MDV N/A
  • IPSC $244.52
  • Revenue Next Year
  • MDV $1.91
  • IPSC $27.73
  • P/E Ratio
  • MDV N/A
  • IPSC N/A
  • Revenue Growth
  • MDV N/A
  • IPSC 7.88
  • 52 Week Low
  • MDV $13.27
  • IPSC $1.14
  • 52 Week High
  • MDV $18.11
  • IPSC $5.51
  • Technical
  • Relative Strength Index (RSI)
  • MDV 43.21
  • IPSC 39.95
  • Support Level
  • MDV $15.70
  • IPSC $1.20
  • Resistance Level
  • MDV $16.44
  • IPSC $1.29
  • Average True Range (ATR)
  • MDV 0.57
  • IPSC 0.12
  • MACD
  • MDV -0.07
  • IPSC -0.00
  • Stochastic Oscillator
  • MDV 21.39
  • IPSC 15.42

About MDV Modiv Industrial Inc. Class C

Modiv Industrial Inc is a pioneer in the direct-to-consumer commercial real estate product industry. It provides individual investors access to real estate and real estate-related investments designed to provide both income and long-term growth. The Company has invested in single-tenant income-producing properties. Its current business consists of owning, managing, operating, leasing, acquiring, investing in and disposing of commercial real estate assets utilized for industrial manufacturing, as well as a few non-core assets. All of the company's consolidated revenues are derived from company's consolidated real estate properties.

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.

Share on Social Networks: